Needham & Company LLC Issues Positive Forecast for Plexus (NASDAQ:PLXS) Stock Price

Plexus (NASDAQ:PLXS) had its price target lifted by equities researchers at Needham & Company LLC from $165.00 to $206.00 in a report released on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. Needham & Company LLC’s price target would suggest a potential upside of 4.25% from the stock’s previous close.

A number of other analysts also recently commented on the stock. Sidoti downgraded shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective for the company. in a report on Friday, October 24th. Benchmark increased their price target on Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a report on Wednesday. Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Stifel Nicolaus set a $150.00 target price on Plexus in a report on Friday, October 24th. Finally, Williams Trading set a $195.00 price target on shares of Plexus in a research note on Wednesday. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $179.20.

Plexus Stock Up 9.3%

Shares of PLXS opened at $197.60 on Friday. The stock has a 50 day moving average price of $158.75 and a 200 day moving average price of $145.40. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.77 and a current ratio of 1.58. The stock has a market capitalization of $5.29 billion, a price-to-earnings ratio of 30.73 and a beta of 0.81. Plexus has a one year low of $103.43 and a one year high of $198.76.

Plexus (NASDAQ:PLXS) last announced its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.55%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Equities research analysts forecast that Plexus will post 5.9 earnings per share for the current fiscal year.

Insider Activity at Plexus

In related news, Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $143.47, for a total transaction of $71,735.00. Following the sale, the director directly owned 7,665 shares of the company’s stock, valued at $1,099,697.55. This represents a 6.12% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $143.50, for a total transaction of $287,000.00. Following the completion of the transaction, the chief executive officer directly owned 60,714 shares of the company’s stock, valued at $8,712,459. This represents a 3.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 9,674 shares of company stock worth $1,382,876 over the last ninety days. Company insiders own 1.78% of the company’s stock.

Institutional Investors Weigh In On Plexus

Several large investors have recently bought and sold shares of PLXS. Salomon & Ludwin LLC purchased a new position in shares of Plexus in the 3rd quarter valued at about $30,000. Allworth Financial LP lifted its stake in Plexus by 70.1% in the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after acquiring an additional 103 shares during the last quarter. Huntington National Bank lifted its stake in Plexus by 41.5% in the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after acquiring an additional 95 shares during the last quarter. Johnson Financial Group Inc. acquired a new position in Plexus during the 3rd quarter worth approximately $72,000. Finally, CWM LLC increased its position in shares of Plexus by 65.7% in the 2nd quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after purchasing an additional 213 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus News Roundup

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Q1 results beat or matched Street expectations: revenue of $1.07B (+10% y/y) and adjusted (non‑GAAP) EPS $1.78; management set Q2 revenue/EPS guidance above consensus and flagged accelerating sequential growth driven by program ramps. Plexus Announces Fiscal First Quarter Financial Results
• Positive Sentiment: High-value program wins and market-share gains: Plexus won 22 new manufacturing programs with $283M of annualized revenue potential (record quarterly Aerospace/Defense wins), supporting management’s view that FY26 revenue growth could meet or exceed the high end of its 9–12% target. Seeking Alpha: Revenue Growth Potential
• Positive Sentiment: Analyst support: Benchmark raised its price target to $195 and reiterated a Buy; Needham/other analysts have also been supportive/upgrading targets after the quarter — analyst action likely amplified buying. Benchmark Boosts Plexus Price Target TipRanks: Needham $206 PT
• Positive Sentiment: Capital return and buybacks: management repurchased $22.4M of shares under the $100M authorization, supporting per-share metrics and investor sentiment. Press Release (buybacks)
• Neutral Sentiment: Analyst views are not unanimous — some outlets characterize opinions as mixed on tech names including Plexus; this tempers uniform bullishness. Globe & Mail: Mixed Analyst Opinions
• Neutral Sentiment: Detailed readouts/transcript available for investors reviewing guidance detail and management commentary on program ramps and end-market demand. Earnings Call Transcript
• Negative Sentiment: Cash and profitability caveats: GAAP diluted EPS declined sequentially (to $1.51) and the quarter produced negative free cash flow (~$50.6M) as working capital and inventory rose to support ramps — short-term cash pressure and inventory build are risks. QuiverQuant: Q1 Results and Cash Flow
• Negative Sentiment: Insider selling and customer concentration: recent disclosures show multiple insider stock sales and top‑10 customers accounted for ~52% of revenue — both are monitoring points for investors. QuiverQuant: Insider Activity & Customer Mix

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.